Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Products & comparisons
Product source

Magnesium Priority by Life Priority: DSLD Label Record 334607

A US dietary supplement label record: Magnesium Priority from Life Priority is listed as a capsule in the mineral category, declaring 200 mg magnesium per labelled serving as magnesium bisglycinate. The record entered the NIH database in September 2025 and shows label declarations only. [1]

Automatic summary · not editorially reviewed

Label · NIH DSLD
Magnesium PriorityOriginal label · NIH DSLD
Magnesium Priority

FROM THE ORIGINAL LABEL

A closer look at the product

Pack contents
90 Capsule(s)
Label serving
3–6 Capsule(s)
Servings per container
30
Barcode / SKU
6 89771 51105 4
Open original label (PDF)
Ingredients & declared amounts1

Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.

IngredientAmountPer label serving
Magnesium200 mg3 Capsule(s)

Other ingredients: Cellulose, Ascorbyl Palmitate

Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.

The key findings

  1. The record is DSLD number 334607 for Magnesium Priority, brand Life Priority. [1]

  2. The label declares a capsule form and 200 mg magnesium per labelled serving as magnesium bisglycinate. [1]

  3. DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. [1]

The source at a glance

Brand
Life Priority
Form
Capsule
Pack contents
90 Capsule(s)
Label serving
3–6 Capsule(s)
Ingredients listed
Magnesium
Record type / format
Dietary supplement label/database record (DSLD), not a study.
Scope / context
The described product: Magnesium Priority capsules by Life Priority, not a patient population.
Summary based on
Product label / database record

Product and database record identified

This page describes a record in the Dietary Supplement Label Database (DSLD) of the NIH Office of Dietary Supplements. The record number is 334607. The label name is Magnesium Priority and the declared brand is Life Priority. The label entered the database on 25 September 2025; the source notes this is not a product launch date. The record is a snapshot of what the label declares, not a test of the product.

Supporting source [1]

Capsule form and declared magnesium amount

The label lists the physical form as a capsule. The DSLD product category is mineral. The declared ingredient is magnesium, in the labelled form magnesium bisglycinate, at 200 mg per labelled serving. These amounts are label facts, not personal dosing advice. The record supplies no independent product testing, no price and no batch certificate.

Supporting source [1]

What the DSLD listing does not establish

According to the source, inclusion in the DSLD does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. The record therefore documents a label declaration only. It does not show that the product works, that it is approved, or that it can currently be bought.

Supporting source [1]

How to interpret this

Product label record; not evidence of efficacy or approval. The record contains label declarations only, with no independent testing, price or batch certificate.

Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.

Source & supporting passages

[1]
Magnesium Priority

Life Priority · dsld.od.nih.gov

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    Record 334607. Product label name: Magnesium Priority
  2. Finding 2 ↑

    Magnesium Bisglycinate): 200 mg per labelled serving
  3. Finding 3 ↑

    DSLD inclusion does not establish efficacy, safety,

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…